MyFinsight
Home
Blog
About
Contact
Download
Download image
Net (loss) income
-$39,222K
(loss) income before
taxes
-$39,222K
Total other loss, net
-$26,419K
(loss) income from
operations
-$12,803K
Change in fair value of
warrants
-$84,934K
Other income, net
$290K
Loss on issuance of
warrants
-$75,644K
Total operating costs
and expenses
$12,803K
Change in fair value of
convertible notes
-$22,911K
Loss on derivative
liability
$13,088K
Change in fair value of
contingent consideration
-$3,499K
Selling, general and
administrative
$12,208K
Research and development
$4,094K
Back
Back
Income Statement
source: myfinsight.com
AEON Biopharma, Inc. (AEON)
AEON Biopharma, Inc. (AEON)